ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
August 2, 2018 4:05 PM EDTRevenue increased 12% to $623.6 million; up 10% on a constant currency basis Net income increased by 8%; non-GAAP net income up 24% GAAP diluted earnings per share of $0.76; non-GAAP diluted earnings per share of $0.95 Operating cash flow of $129.4 million in the fourth quarter Quarterly dividend increased by 6% to $0.37 per share
SAN DIEGO--(BUSINESS WIRE)-- ResMed Inc. (NYSE: RMD) (ASX: RMD) today announced results for... More
